☰

Gloriane W. Schnabolk, Ph.D. - Publications

Affiliations: 
2009 Medical University of South Carolina, Charleston, SC, United States 
Area:
Molecular Biology, Pharmacology, Pharmaceutical Chemistry
Tree Info Similar researchers PubMed Report error

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Schnabolk G, Obert E, Banda NK, Rohrer B. Systemic Inflammation by Collagen-Induced Arthritis Affects the Progression of Age-Related Macular Degeneration Differently in Two Mouse Models of the Disease. Investigative Ophthalmology & Visual Science. 61: 11. PMID 33289791 DOI: 10.1167/iovs.61.14.11  0.73
2020 Schnabolk G. Systemic Inflammatory Disease and AMD Comorbidity. Advances in Experimental Medicine and Biology. 1185: 27-31. PMID 31884584 DOI: 10.1007/978-3-030-27378-1_5  0.416
2019 Schnabolk G, Rohrer B, Simpson KN. Increased Nonexudative Age-Related Macular Degeneration Diagnosis Among Medicare Beneficiaries With Rheumatoid Arthritis. Investigative Ophthalmology & Visual Science. 60: 3520-3526. PMID 31412111 DOI: 10.1167/Iovs.18-26444  0.622
2019 Parsons N, Annamalai B, Obert E, Schnabolk G, Tomlinson S, Rohrer B. Inhibition of the alternative complement pathway accelerates repair processes in the murine model of choroidal neovascularization. Molecular Immunology. 108: 8-12. PMID 30763805 DOI: 10.1016/J.Molimm.2019.02.001  0.71
2018 Schnabolk G, Parsons N, Obert E, Annamalai B, Nasarre C, Tomlinson S, Lewin AS, Rohrer B. Delivery of CR2-fH Using AAV Vector Therapy as Treatment Strategy in the Mouse Model of Choroidal Neovascularization. Molecular Therapy. Methods & Clinical Development. 9: 1-11. PMID 29234687 DOI: 10.1016/J.Omtm.2017.11.003  0.715
2017 Schnabolk G, Beon MK, Tomlinson S, Rohrer B. New Insights on Complement Inhibitor CD59 in Mouse Laser-Induced Choroidal Neovascularization: Mislocalization After Injury and Targeted Delivery for Protein Replacement. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. PMID 28333572 DOI: 10.1089/jop.2016.0101  0.588
2017 Rohrer B, Schnabolk G, Annamalei B, Parsons N, Potts J, Lewin A, Tomlinson SM. Delivery of CR2-fH using AAV vector therapy and encapsulated cell technology as treatment strategies in mouse model of neovascularization Molecular Immunology. 89: 202. DOI: 10.1016/J.Molimm.2017.06.230  0.604
2016 Woodell A, Jones BW, Williamson T, Schnabolk G, Tomlinson S, Atkinson C, Rohrer B. A Targeted Inhibitor of the Alternative Complement Pathway Accelerates Recovery From Smoke-Induced Ocular Injury. Investigative Ophthalmology & Visual Science. 57: 1728-37. PMID 27064393 DOI: 10.1167/Iovs.15-18471  0.718
2016 Coughlin B, Schnabolk G, Joseph K, Raikwar H, Kunchithapautham K, Johnson K, Moore K, Wang Y, Rohrer B. Connecting the innate and adaptive immune responses in mouse choroidal neovascularization via the anaphylatoxin C5a and γδT-cells. Scientific Reports. 6: 23794. PMID 27029558 DOI: 10.1038/Srep23794  0.732
2015 Schnabolk G, Coughlin B, Joseph K, Kunchithapautham K, Bandyopadhyay M, O'Quinn EC, Nowling T, Rohrer B. Local production of the alternative pathway component factor B is sufficient to promote laser-induced choroidal neovascularization. Investigative Ophthalmology & Visual Science. 56: 1850-63. PMID 25593023 DOI: 10.1167/Iovs.14-15910  0.746
2014 Schnabolk G, Stauffer K, O'Quinn E, Coughlin B, Kunchithapautham K, Rohrer B. A comparative analysis of C57BL/6J and 6N substrains; chemokine/cytokine expression and susceptibility to laser-induced choroidal neovascularization. Experimental Eye Research. 129: 18-23. PMID 25305577 DOI: 10.1016/J.Exer.2014.10.005  0.738
2014 Schnabolk G, Tomlinson S, Rohrer B. The complement regulatory protein CD59: insights into attenuation of choroidal neovascularization. Advances in Experimental Medicine and Biology. 801: 435-40. PMID 24664728 DOI: 10.1007/978-1-4614-3209-8_55  0.617
2010 Schnabolk GW, Gupta B, Mulgaonkar A, Kulkarni M, Sweet DH. Organic anion transporter 6 (Slc22a20) specificity and Sertoli cell-specific expression provide new insight on potential endogenous roles. The Journal of Pharmacology and Experimental Therapeutics. 334: 927-35. PMID 20519554 DOI: 10.1124/Jpet.110.168765  0.613
2006 Schnabolk GW, Youngblood GL, Sweet DH. Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20). American Journal of Physiology. Renal Physiology. 291: F314-21. PMID 16478971 DOI: 10.1152/Ajprenal.00497.2005  0.604
Show low-probability matches.